| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Dr. Tsao is Medical Oncology Fellow, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
Dr. Kim is Assistant Professor, Director of Educational Programs, Department of Thoracic & Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.
Dr. Hong is Head, Division of Cancer Medicine, Professor/Chair, Department of Thoracic & Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.
Cancer chemoprevention is defined as the use of natural, synthetic, or biologic chemical agents to reverse, suppress, or prevent carcinogenic progression to invasive cancer. The success of several recent clinical trials in preventing cancer in high-risk populations suggests that chemoprevention is a rational and appealing strategy. This review will highlight current clinical research in chemoprevention, the biologic effects of chemopreventive agents on epithelial carcinogenesis, and the usefulness of intermediate biomarkers as markers of premalignancy. Selected chemoprevention trials are discussed with a focus on strategies of trial design and clinical outcome. Future directions in the field of chemoprevention will be proposed that are based on recently acquired mechanistic insight into carcinogenesis.
This article has been cited by other articles:
|
|
 |
|
  R. Agarwal and G. Deep Kava, a Tonic for Relieving the Irrational Development of Natural Preventive Agents Cancer Prevention Research, November 1, 2008; 1(6): 409 - 412. [Full Text] [PDF]
|
|
|
|
|
|
T. E. Johnson, F. Kassie, M. G. O'Sullivan, M. Negia, T. E. Hanson, P. Upadhyaya, P. P. Ruvolo, S. S. Hecht, and C. Xing Chemopreventive Effect of Kava on 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone plus Benzo[a]pyrene-Induced Lung Tumorigenesis in A/J Mice Cancer Prevention Research, November 1, 2008; 1(6): 430 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jankowski and R. Hunt Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Counterpoint Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 1858 - 1861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bhutani, A. K. Pathak, Y.-H. Fan, D. D. Liu, J. J. Lee, H. Tang, J. M. Kurie, R. C. Morice, E. S. Kim, W. K. Hong, et al. Oral Epithelium as a Surrogate Tissue for Assessing Smoking-Induced Molecular Alterations in the Lungs Cancer Prevention Research, June 1, 2008; 1(1): 39 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Yoon, J. Shen, R. M. Santella, D. J. Zegarelli, R. Chen, and I.B. Weinstein Activated Checkpoint Kinase 2 Expression and Risk for Oral Squamous Cell Carcinoma Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2768 - 2772. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-C. Hou, Y.-P. Chen, J.-H. Wu, C.-C. Huang, S.-Y. Wang, N.-S. Yang, and L.-F. Shyur A Galactolipid Possesses Novel Cancer Chemopreventive Effects by Suppressing Inflammatory Mediators and Mouse B16 Melanoma Cancer Res., July 15, 2007; 67(14): 6907 - 6915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Herberman, H. L. Pearce, S. M. Lippman, B. S. Pyenson, and D. S. Alberts Cancer Chemoprevention and Cancer Preventive Vaccines--A Call to Action: Leaders of Diverse Stakeholder Groups Present Strategies for Overcoming Multiple Barriers to Meet an Urgent Need Cancer Res., December 15, 2006; 66(24): 11540 - 11549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-c. Chen, R. Wang, X. Zhao, Y.-q. Wei, M. Hu, Y.-s. Wang, X.-w. Zhang, R. Zhang, L. Zhang, B. Yao, et al. Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered MSCs Carcinogenesis, December 1, 2006; 27(12): 2434 - 2441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. V. Tyler Jr. and C. W. Snyder Cancer Risk Assessment: Examining the Family Physician's Role J Am Board Fam Med, September 1, 2006; 19(5): 468 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Yun, M.-H. Kweon, H. Kwon, J.-K. Hwang, and H. Mukhtar Induction of apoptosis and cell cycle arrest by a chalcone panduratin A isolated from Kaempferia pandurata in androgen-independent human prostate cancer cells PC3 and DU145 Carcinogenesis, July 1, 2006; 27(7): 1454 - 1464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G Baker and J. Kaprio Common susceptibility genes for cancer: search for the end of the rainbow. BMJ, May 13, 2006; 332(7550): 1150 - 1152. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Shukla and S. Gupta Molecular targets for apigenin-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft. Mol. Cancer Ther., April 1, 2006; 5(4): 843 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Chen, H. Hwang, M. E. Rose, R. G. Nines, and G. D. Stoner Chemopreventive Properties of Black Raspberries in N-Nitrosomethylbenzylamine-Induced Rat Esophageal Tumorigenesis: Down-regulation of Cyclooxygenase-2, Inducible Nitric Oxide Synthase, and c-Jun. Cancer Res., March 1, 2006; 66(5): 2853 - 2859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. K. Basuroy and E. W. Gerner Emerging Concepts in Targeting the Polyamine Metabolic Pathway in Epithelial Cancer Chemoprevention and Chemotherapy J. Biochem., January 1, 2006; 139(1): 27 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wislez, M. L. Spencer, J. G. Izzo, D. M. Juroske, K. Balhara, D. D. Cody, R. E. Price, W. N. Hittelman, I. I. Wistuba, and J. M. Kurie Inhibition of Mammalian Target of Rapamycin Reverses Alveolar Epithelial Neoplasia Induced by Oncogenic K-ras Cancer Res., April 15, 2005; 65(8): 3226 - 3235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Singh, P. Agrawal, D. Yim, C. Agarwal, and R. Agarwal Acacetin inhibits cell growth and cell cycle progression, and induces apoptosis in human prostate cancer cells: structure-activity relationship with linarin and linarin acetate Carcinogenesis, April 1, 2005; 26(4): 845 - 854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wen, U.K. Walle, and T. Walle 5,7-Dimethoxyflavone downregulates CYP1A1 expression and benzo[a]pyrene-induced DNA binding in Hep G2 cells Carcinogenesis, April 1, 2005; 26(4): 803 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-Y. Han, D. D. Liu, J. J. Lee, J. Kurie, R. Lotan, W. K. Hong, and H.-Y. Lee 9-cis-Retinoic Acid Treatment Increases Serum Concentrations of {alpha}-Tocopherol in Former Smokers Clin. Cancer Res., March 15, 2005; 11(6): 2305 - 2311. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
